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ABSTRACT
Influenza is one of the most common respiratory diseases in the world, annually causing over one million 
of deaths� It is triggered by one of the influenza viruses (A, B, or C)� In most cases, it occurs in epidemic 
form, but it can also appear in pandemic form, and very occasionally, it occurs in sporadic form� In the 
temperate zones, influenza occurs during the winter months of a year� In the tropics, however, it occurs 
throughout the year, although the highest number of patients is registered during the rainy seasons� In 
young and otherwise healthy individuals influenza is a mild disease; however, if affecting individuals with 
a weakened immune system, it can lead to health complications and even to death� The only effective 
preventive measure to preclude the disease is vaccination� There is still no consensus on whether the 
vaccination should be compulsory or recommended and which population groups should be vaccinated� 
In most European countries, the vaccination is recommended for some population groups, while in the 
United States the vaccination is recommend to all individuals above six months of age�
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INTRODUCTION
Acute respiratory infections are the most common 
infections in the world. They cause significant mor-
bidity and mortality, particularly in elderly people 
and pregnant women with history of health prob-
lems. A significant increase in overall mortality was 
registered in the countries of the Northern hemi-
sphere during the 2014-2015 winter season. In Italy, 
for example, this increase amounted to +13% and 
was directly associated with influenza virus circula-
tion (1).
Acute respiratory infections are caused by different 
types of microorganisms. Most commonly, they are 
associated with influenza type  A and B, and less 
commonly with influenza C virus. Thus, influenza 
(also known as the flu) is considered to be one of 
the most common acute respiratory infections. Each 
year, the flu causes over one million of deaths world-
wide (2).
The pandemic influenza viruses have an exception-
ally high impact on morbidity and mortality, as it 
was demonstrated in 2009, when the influenza A 
subtype H1N1 led to a pandemic, causing the death 
of 18,449 people in only one month of that year (3).
Influenza viruses are constantly circulating, but 
their concentration in open space is never that high 
to get infected when spending time outside. The 
outbreak of influenza is more commonly associated 
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with indoor spaces due to the presence of a larger 
number of people at one place, including individ-
uals with the flu. Related to that is the fact that in 
the temperate zones, influenza is a seasonal disease, 
occurring during cold or winter seasons, when 
humidity and temperature are low, and people have 
to spend most of the time indoor (4,5). The highest 
rate of the infection occurs in the period between 
January and April (6). In tropical areas, where the 
virus circulation varies little throughout the year, 
the highest number of patients is registered during 
the rainy seasons.
Usually, a large number of people is affected by 
influenza at the same time, thus the epidemic form 
is more common than the sporadic form. The occur-
rence of the disease is determined by environmental 
and social factors. The most important environmen-
tal factors are outdoor temperature and humidity, 
while social factors include equality in health care 
system, availability of vaccine, and the age of popu-
lation. These factors play a major role in occurrence 
and spread of influenza (7).
Seasonal influenza causes a significant burden 
to public health system due to a large number of 
affected people who cannot effectively perform their 
daily tasks and contribute to the society. At the same 
time, these patients spend more money to purchase 
the analgesics, antipyretics, and food rich in vita-
mins compared with healthy people.
INFLUENZA CHARACTERISTICS
Although everyone can be affected by influenza 
regardless of gender and age, various epidemics 
and pandemics occur differently within certain age 
groups. For example, during the pandemic influenza 
that occurred in 2009, the largest number of patients 
were in the age group between 21 and 30 years.
Influenza begins with general infectious syndrome 
(general weakness, fatigue, fever, pain in the bones 
and joints) and continues with symptoms of respi-
ratory tract infection (sneezing, coughing, runny 
nose, and watery eyes).
At the beginning of epidemics, the disease is hard 
to diagnose due to the sporadic form of influenza, 
and laboratory testing is required. Polymerase 
chain reaction (PCR) is the best method for virus 
identification. In addition, to determine the diag-
nosis, it is very important to have the epidemiolog-
ical data on co-occurrence of similar diseases in the 
patient’s environment, as well as to have data on the 
movement of influenza during the same period in 
several previous years.
Respiratory diseases caused by respiratory syncytial 
virus (RSV), which frequently affects young chil-
dren (8), often pose diagnostic problems when diag-
nosing influenza.
Although, the clinical picture is mild in most cases 
and the disease ends in patient’s healing, in some cases, 
influenza can cause various complications. These com-
plications are common in individuals with a weakened 
immune system, such as elderly people and patients 
with chronic diseases [e.g., heart and vascular diseases, 
chronic lung diseases, uncontrolled diabetes mellitus, 
and oncological diseases] (9). The flu can also be a seri-
ous disease for pregnant women because they are at 
increased risk of developing complications compared 
with other individuals of the same age (10).
In general, the most common influenza complica-
tions are pneumonia, otitis media, inflammation of 
the heart muscle, and deterioration of the under-
lying (already existing) illness. In the most severe 
cases, the flu can also lead to death (11).
INFLUENZA VACCINATION
It is generally accepted that vaccination is the only 
effective preventive measure against influenza. 
Moreover, vaccination is especially important when 
the influenza is caused by the viruses with pandemic 
potential, where it is used to prevent or at least to 
control pandemic influenza (12).
A number of studies investigated an optimal vaccina-
tion strategy against influenza viruses, which includes 
the need for vaccination, sufficient quantities of the 
influenza vaccine, and satisfactory vaccination cover-
age. An important segment of the vaccination policy 
is related to the time frame for the implementation 
of the vaccination program (13).
Several dilemmas related to the influenza vaccina-
tion exists, and the two major are:
1. Whether influenza vaccination should be a rec-
ommended or compulsory activity; and
2. Who should be vaccinated against influenza?
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Each country has different approach in determining 
whether the vaccination against influenza should 
be recommended or compulsory, to prevent and 
control seasonal influenza in those areas. In most 
countries, the vaccination against seasonal influenza 
is recommended. Similarly, different countries have 
different recommendations for selecting the target 
groups for influenza vaccination.
Recently, European countries considered to make 
the influenza vaccination compulsory. Children 
aged from 2 to 17 years are proposed as the target 
group. It is assumed that this strategy would directly 
reduce the morbidity in this age group, and, indi-
rectly, it would reduce the morbidity in adults as 
well, considering that 1/3 of all adult diseases are 
prevented in this way (14).
In 2011, the European Union (EU) introduced the 
live attenuated influenza vaccine (LAIV) for healthy 
children and adolescents aged 2-17 years. The vac-
cine is applied intranasally. Simulation studies con-
ducted in Germany indicated that the vaccination of 
this age group would lead to a significant reduction 
in overall morbidity and have a positive economic 
effect on health insurance (15,16).
For the 2015/16 influenza season, the United States 
(US) recommended routine annual influenza vac-
cination for all individuals above 6 months of age 
without contraindications (17). One of the main 
arguments for this recommendation is reducing the 
burden to society caused by the flue each year.
A survey conducted in the US showed that an aver-
age influenza season results in over 30,000 people 
diagnosed with the flu and over 3,500 hospitalized 
patients, directly or indirectly, leading to death in 
over 720 patients. On the other hand, it has been 
proved that the vaccination significantly reduces the 
morbidity and mortality in the US (18).
Target groups for influenza vaccination
Due to frequently reported positive effects of the 
influenza vaccination on morbidity and mortality 
reduction in different parts of the world, a number 
of manuals and guidelines on vaccination have been 
developed. Thus, the European guide focuses on the 
vaccination of particularly vulnerable population 
groups such as individuals over 65 years of age, those 
with a weakened immune system, pregnant women, 
and health care workers. Adequate vaccination cov-
erage of these groups would significantly reduce the 
burden caused by influenza (1). Nevertheless, the 
influenza vaccination coverage in Europe is still rel-
atively low, even when observed per individual risk 
groups (19).
Vaccination of elderly people
One of the most vulnerable groups affected by 
influenza are people aged 65  years and more. It 
is considered that such individuals have weak-
ened immunity, and often suffer from chronic 
diseases that can be significantly worsen by influ-
enza. According to a survey conducted in 2008 in 
European countries, the vaccination coverage of 
individuals over 65 years old differed considerably 
from one part of Europe to another, and ranged 
from 2 to 80%. The lowest coverage was recorded 
in Poland. One of the explanations for the low 
vaccination coverage was that the vaccine was not 
provided free of charge (19).
When considering elderly population, the risk of 
influenza is particularly high in the group accommo-
dated in nursing homes, so the vaccination coverage 
should be a priority in this group. Influenza vaccina-
tion of elderly people would also prevent 50-68% of 
pneumonia cases, as this is one of the most common 
complications of influenza in this population group. 
When the influenza vaccination is not administered 
in time, outbreak of influenza epidemics in nurs-
ing homes is treated by antiretroviral therapy given 
within 12 to 48 hours. When compared to the vac-
cination, such treatment is considerably more com-
plicated for the patients, and more expensive for the 
health care system (20).
Vaccination of individuals with a weakened 
immune system and chronic diseases
Influenza is considered a mild disease for individ-
uals with a healthy immune system, but it can be 
very serious for immunocompromised individuals, 
and those with chronic diseases. Therefore, such 
individuals are in the group recommended for the 
influenza vaccination. This group also includes 
HIV-positive people who need to be vaccinated by 
an inactivated vaccine because the live vaccine could 
further damage their health. To achieve an adequate 
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immune response, the vaccination should be car-
ried out while the patient’s immune system is still 
strong (21).
Since the influenza has a negative impact on various 
chronic diseases, especially chronic respiratory and 
cardiovascular diseases, and can worsen the under-
lying disease condition, the patients suffering from 
such diseases should also be vaccinated against influ-
enza (22,23).
Influenza vaccination of pregnant women
Influenza vaccination of pregnant women is con-
ducted to protect pregnant women and mothers, as 
influenza is more likely to cause severe illness in this 
population group. Pregnant women show a high 
sensitivity to some types of the influenza viruses 
that can even lead to their death. At the same time, 
the vaccination of pregnant women also ensures the 
protection of fetus during the pregnancy as well as 
the protection of newborn babies during the period 
when the vaccine-preventable diseases, including the 
flu, have a significant impact on morbidity and mor-
tality in this age group. The inactive vaccine against 
influenza is recommended for pregnant women. If 
the vaccination is not carried out during the preg-
nancy, it is recommended to be vaccinated after the 
delivery, to protect a newborn child (24,25).
All available data on the effects of vaccination on 
pregnant women and mothers show significant 
benefits for both, a mother and child. Therefore, it 
is necessary to conduct more effective social cam-
paigns as well as to involve more actively gynecolo-
gists and midwives in promoting the vaccination of 
pregnant women (26).
Influenza vaccination of health care workers
In terms of influenza vaccination, health care work-
ers are a particularly important population group to 
consider, for several reasons. Their daily contact with 
patients puts them at a higher risk of getting the 
flu compared with general population. Moreover, 
infected health care workers can easily spread the 
disease, especially to vulnerable groups of patients, 
in which influenza may worsen their pre-existing 
medical conditions, and even cause death. Since the 
70s of the last century, the transmission of influ-
enza viruses in health care institutions has been 
documented, even in the form of intrahospital epi-
demics (27). In addition, health care workers can 
also transmit the flu to their family members (28). 
Nevertheless, not all groups of health care workers 
are equally important to be considered for influenza 
vaccination. For ethical reasons, it is recommended 
to make the vaccination compulsory for health care 
professionals who work with high risk categories 
of patients [e.g.,  premature infants, neonates, the 
elderly, individuals with immune deficiencies and 
chronic diseases] (29). Although the recommenda-
tions for annual vaccination of health care workers 
were issued back in 1984, the vaccination coverage 
has not yet achieved a satisfactory level (30).
A study conducted in France, in 102 centers for 
accommodation and treatment of elderly people, 
pointed out the challenges of the influenza vacci-
nation of health care personnel. The study showed 
lack of motivation and knowledge of health care 
workers about the vaccine and influenza vacci-
nation programs. In addition, the organizational 
issues contributed to low vaccination coverage (31). 
According to the research of Kramarz et al. (32), the 
influenza vaccination coverage is relatively low and 
rarely reaches 40% (32).
Health care professionals employed in care homes 
for elderly people are also at a high risk of getting 
influenza, so their vaccination is an important mea-
sure for the suppression of severe forms of influ-
enza and nosocomial outbreaks in geriatric centers. 
A  group of French authors analyzed published 
articles on geriatrics, infectious diseases, pneumol-
ogy, and vaccination. Their results showed a lack of 
influenza vaccination coverage of workers employed 
in geriatric units. The lowest vaccination coverage 
was identified among young non-health care female 
workers (33).
Health care workers should undergo influenza vac-
cination for their own protection, protection of 
their families, and patients with whom they work. 
Among the factors that influence the decision to 
refuse vaccination are: the fear of vaccines, fear of 
adverse reactions, distrust in the effectiveness of vac-
cination, inadequate understanding of the impact of 
vaccination on health or disease. Related to this are 
also problems with the organization of the vaccina-
tion program (32).
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A number of health care authorities recommend 
routine influenza vaccination for health care work-
ers. This was particularly important during a pan-
demic occurrence of influenza A H1N1 in 2009, 
when the World Health Organization (WHO) rec-
ommended the influenza vaccination for all health 
care workers. In addition the immunization reduces 
the absence of health care workers from work, which 
has positive effects on economy as well.
Currently, 88% of countries recommend the vacci-
nation of health care workers, and 61% also pro-
vides the financial support for the process. There is 
a positive trend in increasing the number of vacci-
nated health care workers as a result of education on 
the importance of vaccination, and its easier accessi-
bility and availability (2).
According to the results of studies conducted 
between 1985 and 2002, the vaccination coverage 
of health care workers ranged from 2.1 to 82%. 
Vaccination campaigns included both training of 
health care workers and easier access to vaccines. 
The two main reported obstacles were: inadequate 
influenza risk assessments and underestimation of a 
risk to transmit the disease to patients. It is therefore 
important to make a vaccination campaign adapted 
to the specific requirements of each health care insti-
tution (34).
Vaccination of health care workers in a Saudi hospi-
tal in the 2008-2009 season was relatively low and 
covered 34.4% of the health care personnel. Ninety-
five percent of the workers agreed to vaccination for 
their own protection, while doubts on the effective-
ness of the vaccine in preventing the disease were the 
main reason in the worker group who refused to be 
vaccinated (35).
CONCLUSION
Influenza is an acute respiratory disease, which 
annually affects a large number of people. Influenza 
is a mild disease in young, otherwise healthy people. 
However, it can cause severe complications and even 
death in patients suffering from chronic diseases or 
with low immunity. Vaccination is the best preven-
tive measure to suppress the influenza virus, but the 
dilemma whether to make this vaccination compul-
sory or recommended and which groups should be 
subjected to vaccination have not been resolved yet. 
Based on their experience, many countries reported 
that influenza vaccination should be compulsory for 
the following groups: people over 65 years of age, 
individuals with weakened immune system, preg-
nant women, and health care workers. The vaccina-
tion of these population groups would significantly 
reduce their morbidity and mortality rates, and at 
the same time, bring considerable financial savings.
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